FGL1 was also shown to be associated with cell-cycle regulation in pancreatic ductal adenocarcinoma (PDAC), as the downregulation of FGL1 promotes the arrest at the G2/M cell cycle and the expression of Cyclin B1, inhibiting the growth of tumor cells [34]. Here, FGL1 is linked to pancreatic ductal adenocarcinoma.